X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7) 7
adult (6) 6
female (6) 6
humans (6) 6
male (5) 5
young adult (5) 5
adolescent (4) 4
antiretroviral drugs (4) 4
child (4) 4
clinical trials (4) 4
hiv infections - drug therapy (4) 4
human immunodeficiency virus--hiv (4) 4
infectious diseases (4) 4
medicine, general & internal (4) 4
middle aged (4) 4
abridged index medicus (3) 3
adults (3) 3
africa south of the sahara (3) 3
aged (3) 3
antiviral agents (3) 3
cd4 antigen (3) 3
cd4 lymphocyte count (3) 3
children (3) 3
developing countries--ldcs (3) 3
drug therapy (3) 3
hiv (3) 3
lopinavir (3) 3
medical research (3) 3
mortality (3) 3
raltegravir (3) 3
tuberculosis (3) 3
adolescents (2) 2
anti-retroviral agents - administration & dosage (2) 2
antiretroviral therapy (2) 2
article (2) 2
care and treatment (2) 2
child, preschool (2) 2
councils (2) 2
disease control (2) 2
dosage and administration (2) 2
drug therapy, combination (2) 2
efavirenz (2) 2
health aspects (2) 2
hiv infection (2) 2
hiv infections - mortality (2) 2
immunology (2) 2
isoniazid - therapeutic use (2) 2
nucleosides (2) 2
raltegravir potassium - administration & dosage (2) 2
research (2) 2
risk (2) 2
ritonavir (2) 2
therapy (2) 2
viral load - drug effects (2) 2
virology (2) 2
abacavir (1) 1
acquired immune deficiency syndrome--aids (1) 1
active antiretroviral therapy (1) 1
adverse events (1) 1
africa (1) 1
africa - epidemiology (1) 1
africa south of the sahara - epidemiology (1) 1
aids-related opportunistic infections - prevention & control (1) 1
aids/hiv (1) 1
albendazole (1) 1
albendazole - administration & dosage (1) 1
albendazole - adverse effects (1) 1
alcohol abstinence (1) 1
amplification (1) 1
analysis (1) 1
anthelmintics (1) 1
anthelmintics - administration & dosage (1) 1
anthelmintics - adverse effects (1) 1
anti-hiv agents - administration & dosage (1) 1
anti-hiv agents - therapeutic use (1) 1
anti-infective agents - administration & dosage (1) 1
anti-infective agents - adverse effects (1) 1
anti-infective agents - therapeutic use (1) 1
anti-retroviral agents - adverse effects (1) 1
anti-retroviral agents - therapeutic use (1) 1
antiretroviral agents (1) 1
antiretroviral drug concentrations (1) 1
antiretroviral therapy, highly active (1) 1
antiretroviral-naive subjects (1) 1
antitubercular agents - therapeutic use (1) 1
arachis (1) 1
articles (1) 1
association (1) 1
azithromycin (1) 1
biology and life sciences (1) 1
biomarkers (1) 1
biomedicine (1) 1
blood (1) 1
body mass index (1) 1
body weight (1) 1
candidiasis (1) 1
cd4-positive t-lymphocytes - drug effects (1) 1
cd4-positive t-lymphocytes - pathology (1) 1
cd4-positive t-lymphocytes - virology (1) 1
communicable diseases - immunology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 3, pp. 233 - 245
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 3, pp. 234 - 247
Journal Article
PLoS medicine, ISSN 1549-1676, 12/2018, Volume 15, Issue 12, p. e1002706
Background In sub-Saharan Africa, individuals infected with HIV who are severely immunocompromised have high mortality (about 10%) shortly after starting... 
MORTALITY | BIOMARKERS | SOUTH-AFRICA | MEDICINE, GENERAL & INTERNAL | IMMUNE RECONSTITUTION | EFAVIRENZ | ADULTS | INFECTION | RESTORATION | IMMUNODEFICIENCY | CHILDREN | HIV Infections - diagnostic imaging | Africa - epidemiology | Zimbabwe - epidemiology | Drug Administration Schedule | Follow-Up Studies | Kenya - epidemiology | HIV Infections - epidemiology | Humans | Raltegravir Potassium - administration & dosage | Child, Preschool | Malawi - epidemiology | Uganda - epidemiology | Male | Disease Progression | Anti-HIV Agents - administration & dosage | Young Adult | Anti-Retroviral Agents - administration & dosage | Adolescent | Adult | Female | HIV Infections - drug therapy | Child | Health Services Accessibility - trends | Drug therapy | HIV infection | Raltegravir | Testing | Therapy | RNA-directed DNA polymerase | Viremia | Funding | Clinical trials | Risk | Viruses | Infections | Tenofovir | Randomization | Motivation | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Children | Adolescents | Genotypes | Supervision | University colleges | Integrase | Antiretroviral drugs | Medical research | Mortality | Immune reconstitution | Inflammation | Disease control | Antiretroviral therapy | Morbidity | CD4 antigen | Medicine | Amplification | Non-nucleoside reverse transcriptase inhibitors | Inhibitors | Councils | Abacavir | Nucleosides | Biomarkers | Mutation | HIV | Human immunodeficiency virus
Journal Article
by Hakim, James G and Thompson, Jennifer and Kityo, Cissy and Hoppe, Anne and Kambugu, Andrew and van Oosterhout, Joep J and Lugemwa, Abbas and Siika, Abraham and Mwebaze, Raymond and Mweemba, Aggrey and Abongomera, George and Thomason, Margaret J and Easterbrook, Philippa and Mugyenyi, Peter and Walker, A Sarah and Paton, Nicholas I and Agweng, E and Awio, P and Bakeinyaga, G and Isabirye, C and Kabuga, U and Kasuswa, S and Katuramu, M and Kiweewa, F and Kyomugisha, H and Lutalo, E and Mulima, D and Musana, H and Musitwa, G and Musiime, V and Ndigendawan, M and Namata, H and Nkalubo, J and Labejja, P Ocitti and Okello, P and Olal, P and Pimundu, G and Segonga, P and Ssali, F and Tamale, Z and Tumukunde, D and Namala, W and Byaruhanga, R and Kayiwa, J and Tukamushaba, J and Abunyang, S and Eram, D and Denis, O and Lwalanda, R and Mugarura, L and Namusanje, J and Nankya, I and Ndashimye, E and Nabulime, E and Senfuma, O and Bihabwa, G and Buluma, E and Elbireer, A and Kamya, D and Katwere, M and Kiggundu, R and Komujuni, C and Laker, E and Lubwama, E and Mambule, I and Matovu, J and Nakajubi, A and Nakku, J and Nalumenya, R and Namuyimbwa, L and Semitala, F and Wandera, B and Wanyama, J and Mugerwa, H and Ninsiima, E and Ssenkindu, T and Mwebe, S and Atwine, L and William, H and Katemba, C and Acaku, M and Ssebutinde, P and Kitizo, H and Kukundakwe, J and Naluguza, M and Ssegawa, K and Namayanja and Nsibuka, F and Tuhirirwe, P and Fortunate, M and Acen, J and Achidri, J and Amone, A and Chamai, M and Ditai, J and Kemigisa, M and Kiconco, M and Matama, C and Mbanza, D and Nambaziira, F and ... and Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team and Europe Africa Res Network
The Lancet Infectious Diseases, ISSN 1473-3099, 01/2018, Volume 18, Issue 1, pp. 47 - 57
Journal Article
Journal of NeuroVirology, ISSN 1355-0284, 2/2016, Volume 22, Issue 1, pp. 104 - 113
Sensory peripheral neuropathy (PN) remains a common complication in HIV-positive patients despite effective combination anti-retroviral therapy (ART). Data on... 
Neurology | Neurosciences | Biomedicine | Immunology | Second-line ART | Tuberculosis | HIV | Africa | Infectious Diseases | Peripheral neuropathy | Virology | RISK-FACTORS | PREVALENCE | SENSORY NEUROPATHY | STAVUDINE | NEUROTOXICITY | NEUROSCIENCES | VIROLOGY | ERA | ACTIVE ANTIRETROVIRAL THERAPY | INFECTED PERSONS | ADVERSE EVENTS | Humans | Middle Aged | Raltegravir Potassium - therapeutic use | Male | RNA, Viral - blood | Tuberculosis, Pulmonary - drug therapy | Peripheral Nervous System Diseases - physiopathology | CD4-Positive T-Lymphocytes - pathology | RNA, Viral - antagonists & inhibitors | HIV-1 - growth & development | Smoking - physiopathology | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Isoniazid - therapeutic use | CD4-Positive T-Lymphocytes - virology | Peripheral Nervous System Diseases - complications | Antitubercular Agents - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Africa South of the Sahara | Logistic Models | Alcohol Abstinence | CD4 Lymphocyte Count | Antiretroviral Therapy, Highly Active | Peripheral Nervous System Diseases - virology | HIV Infections - complications | HIV Infections - drug therapy | Lopinavir - therapeutic use | HIV Infections - physiopathology | Viral Load - drug effects | CD4-Positive T-Lymphocytes - drug effects | Drug Combinations | Peripheral Nervous System Diseases - drug therapy
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2018, Volume 23, Issue 2, pp. 191 - 195
Background: HIV is transmitted primarily through sexual intercourse, and the objective of this study was therefore to assess whether there is occult viral... 
INFECTIOUS DISEASES | RALTEGRAVIR | SEMINAL PLASMA | INFECTED MEN | PENETRATION | LOPINAVIR | TRACT | VIROLOGY | SEMEN | ANTIRETROVIRAL DRUG CONCENTRATIONS | PHARMACOLOGY & PHARMACY | BLOOD | RITONAVIR
Journal Article
by Mallewa, Jane and Szubert, Alexander J and Mugyenyi, Peter and Chidziva, Ennie and Thomason, Margaret J and Chepkorir, Priscilla and Abongomera, George and Baleeta, Keith and Etyang, Anthony and Warambwa, Colin and Melly, Betty and Mudzingwa, Shepherd and Kelly, Christine and Agutu, Clara and Wilkes, Helen and Nkomani, Sanele and Musiime, Victor and Lugemwa, Abbas and Pett, Sarah L and Bwakura-Dangarembizi, Mutsa and Prendergast, Andrew J and Gibb, Diana M and Walker, A Sarah and Berkley, James A and Mugyenyi, Peter and Kityo, Cissy and Musiime, Victor and Wavamunno, Priscilla and Nambi, Esther and Ocitti, Paul and Ndigendawani, Milly and Kabahenda, Sheila and Kemigisa, Mable and Acen, Juliet and Olebo, David Francis and Mpamize, Gordon and Amone, Alex and Okweny, David and Mbonye, Andrew and Nambaziira, Florence and Rweyora, Angela and Kangah, Mary and Kabaswahili, Beatrice and Abach, James and Abongomera, George and Omongin, Joseph and Aciro, Irene and Philliam, Aleti and Arach, Beatrice and Ocung, Emmanuel and Amone, Geoffrey and Miles, Peter and Adong, Claudia and Tumsuiime, Constance and Kidega, Patrick and Otto, Ben and Apio, Florence and Baleeta, Keith and Mukuye, Andrew and Abwola, Mary and Ssennono, Fred and Baliruno, David and Tuhirwe, Stephen and Namisi, Ronald and Kigongo, Fredrick and Kikyonkyo, Dickson and Mushahara, Furaha and Tusiime, Julian and Musiime, Alex and Nankya, Agnes and Atwongyeire, Dickens and Sirikye, Sowal and Myalo, Sula and Noowe, Nelson and Lugemwa, Abbas and Kasozi, Mariam and Mwebe, Sandra and Atwine, Lorna and Senkindu, Tapson and Natuhurira, Ian and Katemba, Chrispus and Ninsiima, Emily and Acaku, Moses and Kyomuhangi, Joy and Ankunda, Rogers and Tukwasibwe, Deogratious and Ayesiga, Lillian and Hakim, James and Nathoo, Kusum and Bwakura-Dangarembizi, Mutsa and Reid, Andrew and Chidziva, Ennie and Mhute, Tawand and Tinago, Gloria and Bhiri, Joyline and Mudzingwa, Shepherd and Phiri, Misheck and Steamer, John and Nhema, Ruth and Warambwa, Colin and ... and REALITY trial team and REALITY Trial Team
The Lancet HIV, ISSN 2352-3018, 05/2018, Volume 5, Issue 5, pp. e231 - e240
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 52 - 62
Journal Article